Serum, Pleural Effusion, and Ascites CA-125 Levels in Ovarian Cancer and Nonovarian Benign and Malignant Diseases: A Comparative Study

By Topalak O.   Saygili U.   Soyturk M.   Karaca N.   Batur Y.   Uslu T.   Erten O.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 108-113

Elsevier

Access to resources Recommend Favorite

Differentiation between benign and malignant ovarian masses in the preoperative period using neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios

By  

Molecular and Clinical Oncology, Vol. 3, Iss. 2, 2015-01 ,pp. : 317-321

Science Publishers

Access to resources Recommend Favorite

Preoperative CA-125 Levels in Patients with Hereditary Compared to Sporadic Epithelial Ovarian Carcinoma

By Leitao M.   Boyd J.  

Gynecologic Oncology, Vol. 84, Iss. 3, 2002-03 ,pp. : 413-415

Elsevier

Access to resources Recommend Favorite

Preoperative D-Dimer Plasma Assay Is Not a Predictor of Clinical Outcome for Patients with Advanced Ovarian Cancer

By Gadducci A.   Marrai R.   Baicchi U.   Ferdeghini M.   Fanucchi A.   Weiss C.   Genazzani A.R.  

Gynecologic Oncology, Vol. 66, Iss. 1, 1997-07 ,pp. : 85-88

Elsevier

Access to resources Recommend Favorite

Preoperative differentiation of malignant from benign ovarian tumors: the efficacy of morphology indexing and Doppler flow sonography

By Ueland F.R.   DePriest P.D.   Pavlik E.J.   Kryscio R.J.   van Nagell J.R.  

Gynecologic Oncology, Vol. 91, Iss. 1, 2003-10 ,pp. : 46-50

Elsevier

Access to resources Recommend Favorite